GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.30
-0.40 (-2.03%)
Apr 29, 2026, 1:30 PM CST

GeneReach Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
155.07110.27216.77748.61663.43
Upgrade
Short-Term Investments
114181.01285.95--
Upgrade
Trading Asset Securities
20.69122.7---
Upgrade
Cash & Short-Term Investments
289.76413.98502.72748.61663.43
Upgrade
Cash Growth
-30.01%-17.65%-32.85%12.84%111.50%
Upgrade
Accounts Receivable
39.3743.0521.4755.86195.75
Upgrade
Other Receivables
2.163.371.680.40.72
Upgrade
Receivables
41.5346.4223.1456.26196.47
Upgrade
Inventory
32.5637.5267.37235.81268.3
Upgrade
Prepaid Expenses
1.883.245.888.3634.68
Upgrade
Other Current Assets
118.4393.5133.0121.0317.66
Upgrade
Total Current Assets
484.16594.67632.141,0701,181
Upgrade
Property, Plant & Equipment
284.73359.65433.83436.93397.11
Upgrade
Long-Term Investments
----3.24
Upgrade
Other Intangible Assets
15.4312.412.359.4910.03
Upgrade
Long-Term Deferred Tax Assets
81.7883.2177.6535.2624
Upgrade
Other Long-Term Assets
14.9516.5620.1870.1569.51
Upgrade
Total Assets
881.051,0661,1761,6221,684
Upgrade
Accounts Payable
7.197.748.8613.3531.68
Upgrade
Short-Term Debt
1361711044949
Upgrade
Current Portion of Long-Term Debt
--35.62204.427.5
Upgrade
Current Portion of Leases
11.411.6411.3812.648.54
Upgrade
Current Income Taxes Payable
-73.5923.0874.45
Upgrade
Current Unearned Revenue
3.342.934.967.819.43
Upgrade
Other Current Liabilities
43.239.2137.574.887.62
Upgrade
Total Current Liabilities
201.13239.53205.9385.09278.21
Upgrade
Long-Term Debt
---15217.39
Upgrade
Long-Term Leases
71.784.5997.74108.8987.35
Upgrade
Long-Term Unearned Revenue
9.5310.578.788.958.82
Upgrade
Pension & Post-Retirement Benefits
----1.73
Upgrade
Long-Term Deferred Tax Liabilities
1.996.291.261.281.2
Upgrade
Other Long-Term Liabilities
-0.020.020.021.64
Upgrade
Total Liabilities
284.34341313.71519.23596.35
Upgrade
Common Stock
580.58574.58574.58459.66417.87
Upgrade
Additional Paid-In Capital
150.54144.9144.9144.9144.9
Upgrade
Retained Earnings
-117.32-3.29114.74464.44491.74
Upgrade
Treasury Stock
-17.31----
Upgrade
Comprehensive Income & Other
-9.760.79-2.15-1.33-4.7
Upgrade
Total Common Equity
586.73716.98832.061,0681,050
Upgrade
Minority Interest
9.998.5130.3735.0138.26
Upgrade
Shareholders' Equity
596.72725.49862.441,1031,088
Upgrade
Total Liabilities & Equity
881.051,0661,1761,6221,684
Upgrade
Total Debt
219.1267.23248.74389.95369.78
Upgrade
Net Cash (Debt)
70.67146.75253.98358.66293.65
Upgrade
Net Cash Growth
-51.84%-42.22%-29.19%22.14%133.48%
Upgrade
Net Cash Per Share
1.242.554.426.055.01
Upgrade
Filing Date Shares Outstanding
57.357.4657.4657.4657.46
Upgrade
Total Common Shares Outstanding
57.357.4657.4657.4657.46
Upgrade
Working Capital
283.03355.14426.24684.99902.32
Upgrade
Book Value Per Share
10.2412.4814.4818.5818.27
Upgrade
Tangible Book Value
571.29704.59819.721,0581,040
Upgrade
Tangible Book Value Per Share
9.9712.2614.2718.4218.10
Upgrade
Buildings
296.08293.85292.04267.33266.03
Upgrade
Machinery
306.55332.71309.58273.19231.16
Upgrade
Construction In Progress
0.26--20.95-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.